Figure 2.

Steps towards anti-metastatic therapies. At the preclinical level, efforts should be directed towards the identification of novel anti-metastatic targets. At the clinical level, the current anti-cancer therapeutic clinical trial design should be altered to assure appropriate patient selection and proper step specific therapy readouts.